HER2-Testung beim Magenkarzinom

Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)

(2016) Sook Ryun Park et al.   EUROPEAN JOURNAL OF CANCER

Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer

(2015) Naoyuki Tominaga et al.   Gastric Cancer

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Her2/neu testing in gastric cancer: evaluating the risk of sampling errors

(2012) V. S. Warneke et al.   ANNALS OF ONCOLOGY

HER2 testing in gastric cancer: a practical approach

(2012) Josef Rüschoff et al.   MODERN PATHOLOGY

Quality assessment of HER2 testing by monitoring of positivity rates

(2011) Harald Choritz et al.   VIRCHOWS ARCHIV

S3-Leitlinie „Magenkarzinom” -

(2011) M. Moehler et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Her2-Diagnostik beim Magenkarzinom

(2010) J. Rüschoff et al.   PATHOLOGE

Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients

(2009) J D Barros-Silva et al.   BRITISH JOURNAL OF CANCER

6511 Human epidermal growth factor receptor 2 (HER2) in gastric cancer (GC): results of the ToGA trial screening programme and recommendations for HER2 testing

(2009) H. Chung et al.   EJC SUPPLEMENTS

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

(2008) C. Gravalos et al.   ANNALS OF ONCOLOGY

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

(2008) M Hofmann et al.   HISTOPATHOLOGY